Prioritizing, monitoring key to minimizing risks of polypharmacy
Polypharmacy scenarios are common in elderly patients. Don’t be afraid to deprescribe, but make sure to monitor afterwards, the speakers at an ACR/ARP Annual Meeting session emphasized.